Your browser doesn't support javascript.
loading
Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization.
Willis, Jordan R; Finn, Jessica A; Briney, Bryan; Sapparapu, Gopal; Singh, Vidisha; King, Hannah; LaBranche, Celia C; Montefiori, David C; Meiler, Jens; Crowe, James E.
Afiliación
  • Willis JR; Chemical and Physical Biology Program, Vanderbilt University, Nashville, TN 37232; Center for Structural Biology, Vanderbilt University, Nashville, TN 37232; Vanderbilt Vaccine Center, Vanderbilt University, Nashville, TN 37232;
  • Finn JA; Center for Structural Biology, Vanderbilt University, Nashville, TN 37232; Vanderbilt Vaccine Center, Vanderbilt University, Nashville, TN 37232; Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN 37232;
  • Briney B; Vanderbilt Vaccine Center, Vanderbilt University, Nashville, TN 37232; Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN 37232;
  • Sapparapu G; Vanderbilt Vaccine Center, Vanderbilt University, Nashville, TN 37232; Department of Pediatrics, Vanderbilt University, Nashville, TN 37232;
  • Singh V; Vanderbilt Vaccine Center, Vanderbilt University, Nashville, TN 37232;
  • King H; Vanderbilt Vaccine Center, Vanderbilt University, Nashville, TN 37232;
  • LaBranche CC; Department of Surgery, Duke University Medical Center, Durham, NC 27710;
  • Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, NC 27710;
  • Meiler J; Chemical and Physical Biology Program, Vanderbilt University, Nashville, TN 37232; Center for Structural Biology, Vanderbilt University, Nashville, TN 37232; Department of Chemistry, Vanderbilt University, Nashville, TN 37232; Institute for Chemical Biology, Vanderbilt University, Nashville, TN 3723
  • Crowe JE; Chemical and Physical Biology Program, Vanderbilt University, Nashville, TN 37232; Vanderbilt Vaccine Center, Vanderbilt University, Nashville, TN 37232; Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN 37232; Department of Pediatrics, Vanderbilt University
Proc Natl Acad Sci U S A ; 113(16): 4446-51, 2016 Apr 19.
Article en En | MEDLINE | ID: mdl-27044078
ABSTRACT
Development of broadly neutralizing antibodies (bnAbs) against HIV-1 usually requires prolonged infection and induction of Abs with unusual features, such as long heavy-chain complementarity-determining region 3 (HCDR3) loops. Here we sought to determine whether the repertoires of HIV-1-naïve individuals contain Abs with long HCDR3 loops that could mediate HIV-1 neutralization. We interrogated at massive scale the structural properties of long Ab HCDR3 loops in HIV-1-naïve donors, searching for structured HCDR3s similar to those of the HIV-1 bnAb PG9. We determined the nucleotide sequences encoding 2.3 × 10(7)unique HCDR3 amino acid regions from 70 different HIV-1-naïve donors. Of the 26,917 HCDR3 loops with 30-amino acid length identified, we tested 30 for further study that were predicted to have PG9-like structure when chimerized onto PG9. Three of these 30 PG9 chimeras bound to the HIV-1 gp120 monomer, and two were neutralizing. In addition, we found 14 naturally occurring HCDR3 sequences that acquired the ability to bind to the HIV-1 gp120 monomer when adding 2- to 7-amino acid mutations via computational design. Of those 14 designed Abs, 8 neutralized HIV-1, with IC50values ranging from 0.7 to 98 µg/mL. These data suggest that the repertoire of HIV-1-naïve individuals contains rare B cells that encode HCDR3 loops that bind or neutralize HIV-1 when presented on a PG9 background with relatively few or no additional mutations. Long HCDR3 sequences are present in the HIV-naïve B-cell repertoire, suggesting that this class of bnAbs is a favorable target for rationally designed preventative vaccine efforts.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Proteína gp120 de Envoltorio del VIH / VIH-1 / Cadenas Pesadas de Inmunoglobulina / Regiones Determinantes de Complementariedad / Anticuerpos Neutralizantes Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Proteína gp120 de Envoltorio del VIH / VIH-1 / Cadenas Pesadas de Inmunoglobulina / Regiones Determinantes de Complementariedad / Anticuerpos Neutralizantes Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2016 Tipo del documento: Article